摘要
中国药品采购政策发展始于建国初期的统购统销模式,目前以省为单位进行集中采购。根据交易成本、规模经济等经济学理论以及国际发达国家和地区的相关经验,药品集中采购模式是中国药品采购政策发展的必然选择。我们建议中国药品集中采购应当回归药品采购本质,保障药品供应,降低采购成本。同时充分遵循市场规律,信守契约精神,让市场机制起到资源配置的关键作用。
The development of drug procurement policy in China started from the state monopoly over drug purchase and marketing during the initialstage of new China to the now drug centralized procurement policy at provincial scale. According to several economic theories such as transactioncosts and Economies of scale, following the relevant experience of developed countries, drug centralized procurement is a necessary choice for thedevelopment of drug procurement policy in China. We recommend that at the present stage, policy making should return to the ultimate goal of drugprocurement in order to better grantee drug supply and reduce purchasing costs. In addition, it is also important to follow the market law, participatewith contract spirit and maintain the commercialconfidentiality.
出处
《药品评价》
CAS
2016年第10期18-20,61,共4页
Drug Evaluation
基金
国家自然科学基金青年科学基金项目(项目编号:71303011)
国家卫生计生委药物政策与基本药物制度司2015年委托课题
关键词
药品集中采购
交易成本
规模经济
市场规律
Drug Centralized Procurement
Transaction Costs
Economies of Scale
Market Law
